Clinical trial
A Phase 2, Open Label, Study of AMDX-2011P as a Retinal Tracer in Participants With Alzheimer's Disease
NCT06514001 is registered in ClinicalTrials.gov with Amydis Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Open Label, Study of AMDX-2011P as a Retinal Tracer in Participants With Alzheimer's Disease
- Lead sponsor
- Amydis Inc.
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- March 7, 2025
- Completion date
- August 31, 2027
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.